Iron Deficiency Anemia: Ferritin, TIBC, Hepcidin, and Treatment Options

The World's Most Prevalent Nutritional Disorder

Iron deficiency anemia (IDA) affects approximately 1.2 billion people worldwide — roughly 15% of the global population — making it the most common nutritional deficiency disorder on Earth, according to the Global Burden of Disease Study 2019. In children under 5 and women of reproductive age in low- and middle-income countries, prevalence exceeds 40%. The condition costs the global economy an estimated $52 billion annually in lost productivity. Yet diagnosis is frequently delayed because early-stage iron depletion causes no anemia at all, only a constellation of subtle symptoms: fatigue, poor concentration, restless legs, and reduced exercise tolerance — symptoms easily attributed to other causes.

The Three-Stage Progression of Iron Deficiency

Iron deficiency progresses through three distinct stages before anemia becomes clinically obvious:

• Stage 1 — Storage depletion: Bone marrow iron stores fall; serum ferritin decreases (<30 ng/mL). Hemoglobin and serum iron remain normal. This stage can last months to years.
• Stage 2 — Transport iron deficiency: Serum iron falls; transferrin saturation drops below 16%; TIBC rises. Erythropoiesis becomes iron-restricted but hemoglobin is still near-normal.
• Stage 3 — Iron deficiency anemia: Hemoglobin falls below 12 g/dL (women) or 13 g/dL (men). Red cells become microcytic and hypochromic. Classic symptoms of anemia emerge.

Interpreting the Iron Panel

The four tests commonly ordered together reveal different aspects of iron metabolism:

Ferritin is an acute-phase reactant — chronic inflammation, liver disease, or infection elevates ferritin independent of iron status. A person with rheumatoid arthritis may have a "normal" ferritin of 80 ng/mL while being profoundly iron-depleted. In inflammatory states, the combination of low transferrin saturation (<16%) and elevated ferritin (>100 ng/mL) characterizes anemia of chronic disease, which requires different management than true IDA.

Hepcidin: The Master Iron Regulator

Hepcidin, a 25-amino-acid peptide produced by the liver, is the central regulator of systemic iron homeostasis. High hepcidin binds to ferroportin — the only known cellular iron exporter — causing its internalization and degradation, blocking iron release from enterocytes, macrophages, and hepatocytes simultaneously. In iron deficiency, hepcidin falls, allowing maximum absorption from the gut. In inflammation, hepcidin rises (triggered by IL-6), explaining why oral iron supplements fail in active inflammatory disease — absorbed iron cannot exit enterocytes and is shed when those cells slough.

This mechanism explains why oral iron works well in straightforward IDA but poorly in chronic kidney disease, cancer-related anemia, or inflammatory bowel disease. It also explains the "alternate-day dosing" finding: a 2017 study in Blood by Moretti et al. showed that iron absorption was higher on alternate days than daily dosing because daily high-dose iron triggers a hepcidin spike that blocks absorption for approximately 24 hours.

Treatment: Oral vs. Intravenous Iron

Absorption Inhibitors and Enhancers

Dietary factors significantly modulate non-heme iron absorption (heme iron from meat absorbs efficiently regardless):

• Calcium and dairy products compete with iron at the divalent metal transporter-1 (DMT-1), reducing absorption by up to 50% when consumed simultaneously. Taking iron with milk is counterproductive.
• Coffee and tea contain polyphenols (chlorogenic acid, tannins) that chelate iron in the gut lumen, reducing absorption by 39–64% in dose-response studies.
• Vitamin C (ascorbic acid) reduces ferric iron (Fe³⁺) to ferrous iron (Fe²⁺), the only form DMT-1 transports. Taking 200 mg of vitamin C with iron increases absorption 2–4 fold.
• Phytates in whole grains and legumes form insoluble iron complexes; soaking, fermenting, or sprouting grains reduces phytate content significantly.

This article is for informational purposes only. Consult a qualified healthcare professional.